Search Results for: Tilray
Tilray Announces Launch of New Medical Cannabis Brand, Symbios
Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today…
Tilray Commences Trading on the Toronto Stock Exchange Under Symbol “TLRY”
Tilray, Inc. (“Tilray”) announced that as of today, May 5, 2021, its shares of class 2 common…
Tilray & Aphria Announce Closing of Transaction That Creates the “New” Tilray – a Global Cannabis Leader
Tilray, Inc. (“Tilray”) and Aphria Inc. (“Aphria”) today announced the completion of the previously announced business…
Tilray Named to Time’s Inaugural List of the Time100 Most Influential Companies
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced…
Tilray Board of Directors Announces Approval of Amendment to Company’s Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal Requirement
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today…
Aphria Inc. Shareholders Overwhelmingly Approve Proposed Arrangement With Tilray, Inc.
Aphria Inc. (“Aphria”) (TSX: APHA and Nasdaq: APHA), a leading global cannabis-lifestyle consumer packaged goods company, today…
Special Meeting of Tilray, Inc. Stockholders Adjourned to April 30
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced…
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Proxy Materials Mailed to Aphria Shareholders and Tilray Stockholders of Record as of Friday, March 12,…
Tilray Receives Approvals to Expand and Commercialize Medical Cannabis Products in New Zealand
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced…
Tilray, Inc. Reports 2020 Full Fiscal Year and Fourth Quarter Results
Revenue Increased 26% to $210.5 Million in 2020 Compared to Prior Year Net Loss $(3.0) Million in Q4 2020…
Recent Comments